Skip to main content

Day: March 23, 2021

Emerging Markets Report: Making a Million

An Emerging Markets Sponsored Commentary ORLANDO, Fla., March 23, 2021 (GLOBE NEWSWIRE) — Breaking news last week from the 4Less Group, Inc. (FLES: OTCQB) announcing that its wholly owned subsidiary Auto Parts 4Less, Inc. which runs Liftkits4less.com had a 41% increase in gross revenue (prior to returns) for February 2021, as compared to the same period in 2020. It’s a tremendous achievement by the Company and it shows growing traction in the marketplace. If you’re following 4Less, you will see year-over-year growth for the same period. It is important to note that the Company’s big, new, coming launch of AutoParts4Less.com is based on the successes of its predecessor, Liftkits4less.com. As such, seeing the mother ship perform well and realizing that the new venture will have similar UX, technology and of course, leadership team,...

Continue reading

Ascendis Pharma A/S Presents 6-Month Open-Label Extension Data from Phase 2 PaTH Forward Trial of TransCon PTH in Adult Hypoparathyroidism at ENDO 2021

COPENHAGEN, Denmark, March 23, 2021 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technologies to create product candidates that address unmet medical needs, today presented the safety and efficacy results of TransCon PTH after six-months of treatment in patients with hypoparathyroidism enrolled in the open-label extension period (OLE) of the phase 2 PaTH Forward Trial, at the Endocrine Society’s annual meeting, taking place virtually from March 20-23, 2021.   “The study demonstrated that a majority of subjects were able to achieve independence from conventional therapeutic supplements, while maintaining serum calcium in the normal range and having clinically meaningful improvements in urine calcium levels, bone turnover markers and bone mineral density...

Continue reading

ION announces commencement of Rights Offering

HOUSTON, March 23, 2021 (GLOBE NEWSWIRE) — ION Geophysical Corporation (NYSE: IO) (the “Company”) today announced that it has commenced its previously announced Rights Offering. The Company is distributing, at no charge, to its holders of common stock, par value $0.01 per share (the “Common Stock”) as of 5:00 p.m. New York City time on March 22, 2021 (the “Record Date”), non-transferable subscription rights (the “Rights”) to purchase (i) $2.78 principal amount of the 8.00% Senior Secured Second Priority Convertible Notes due 2025 (the “Notes”) per Right, at a purchase price of 100% of the principal amount thereof or (ii) 1.08 shares of Common Stock per Right, at a purchase price of $2.57 per whole share of Common Stock; provided that any Notes will only be issued in minimum increments of $1,000 and will be rounded down to the nearest...

Continue reading

Comstock and MCU Commence Philippine Mercury Remediation Operations; First International Remediation and Extraction Facility is Now in Production

VIRGINIA CITY, Nev., March 23, 2021 (GLOBE NEWSWIRE) — Comstock Mining Inc. (NYSE: LODE) (“Comstock” and the “Company”) and Mercury Clean Up LLC (“MCU”), announced today that all of the site construction and mercury system set up and testing was completed in their Clean Mercury Remediation Technologies (“CMRT”) joint venture earlier this month with the system going operational last week. This represents the first commercial mercury remediation system in the province of Davao D’ Oro, Philippines, and the foundation for adding additional remediation systems into this unprecedented, eco-system-wide mercury remediation effort in the Philippines and leading achievement for the U.N’s Minamata Convention, the international treaty designed to protect human health and the environment from emissions and releases of mercury and mercury compounds....

Continue reading

Global Vaccines Market Size 2021 | To Hit USD 93.08 Billion with 10.7% CAGR by 2026

Pune, India, March 23, 2021 (GLOBE NEWSWIRE) — The global vaccines market size is expected to be USD 93.08 billion by 2026, exhibiting a CAGR of 10.7% during the forecast period. The growing prevalence of malaria around the world is a key factor boosting the vaccines market. According to the World Health Organization, in 2017, there were an estimated 219 million cases of malaria in 87 countries. Total funding for malaria control and elimination reached an estimated US$ 3.1 billion in 2017. Contributions from governments of endemic countries amounted to US$ 900 million, representing 28% of total funding. According to the report, published by Fortune Business Insights in a report, titled “Vaccines Market Size, Share & Industry Analysis, By Type (Recombinant/Conjugate/Subunit, Inactivated, Live Attenuated and Toxoid), By Route...

Continue reading

Development of the Annual General Meeting on Tuesday 23 March 2021

ANNOUNCEMENT A.P. Møller – Mærsk A/S – Development of the Annual General Meeting on Tuesday 23 March 2021 The Annual General Meeting of A.P. Møller – Mærsk A/S took place on Tuesday 23 March 2021 as a completely electronic general meeting in accordance with the below agenda.   The Board of Directors had appointed Niels Kornerup, attorney-at-law, as Chairman of the meeting. AgendaReport on the Company’s activities during the past financial year.                           The Chairman of the Board of Directors gave a presentation of the Company’s activities in the past year.Submission of the audited annual report for adoption.        The audited annual report was submitted and adopted.Resolution to grant discharge to directors.        The General Meeting discharged the Directors from their obligations.Resolution...

Continue reading

Forløb af ordinær generalforsamling tirsdag den 23. marts 2021

SELSKABSMEDDELELSE A.P. Møller – Mærsk A/S – Forløb af ordinær generalforsamling tirsdag den 23. marts 2021 Generalforsamling i A.P. Møller – Mærsk A/S afholdtes tirsdag den 23. marts 2021 som fuldstændig elektronisk generalforsamling i henhold til nedenstående dagsorden. Bestyrelsen havde udpeget advokat Niels Kornerup til dirigent.                                                         DagsordenDer afgives beretning om selskabets virksomhed i det forløbne driftsår.Formanden afgav beretning om selskabets virksomhed i det forløbne driftsår.Den reviderede årsrapport fremlægges til godkendelse.Den reviderede årsrapport blev fremlagt og godkendt.Der træffes beslutning om decharge.Generalforsamlingen meddelte bestyrelsen decharge.Der træffes beslutning om anvendelse af overskud, herunder udbyttets størrelse, eller...

Continue reading

Vision Care Market 2021 | To Exhibit a CAGR of 5.6% and Hit USD 192.85 Billion by 2026

Pune, India, March 23, 2021 (GLOBE NEWSWIRE) — The global vision care market size is expected to reach USD 192.85 billion by 2026, exhibiting a CAGR of 5.6% during the forecast period. Increasing awareness regarding ocular diseases in emerging nations is expected to aid the growth of the market.  The increasing adoption of vision care products will boost the vision care market growth in the forthcoming year. In addition, the growing cases of cataracts to create growth opportunities for the market. For instance, according to the World Health Organization, 51% of the world’s blindness is caused due to cataracts. In addition, the increasing risks of cataract incidence predominantly in developing as well as developed countries will fuel demand for vision care. Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/sample/vision-care-market-101731 As...

Continue reading

HEXO Corp to Participate in Wolfe Research Consumer Access Day on March 26, 2021

OTTAWA, March 23, 2021 (GLOBE NEWSWIRE) — HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NYSE: HEXO)  today announced that Chief Executive Officer, Sebastien St-Louis, and Chief Financial Officer, Trent MacDonald, will participate in a live Q&A discussion at the Wolfe Research Consumer Access Day on March 26, 2021. The discussion, planned for 9:15 a.m. ET, will be hosted by Greg Badishkanian, Managing Director and Head of Consumer, and Spencer Hanus, Research Analyst and Staples Sector Lead. For more information, please contact your Wolfe Research representative. About HEXO Corp (TSX: HEXO; NYSE: HEXO) HEXO Corp is an award-winning consumer packaged goods cannabis company that creates and distributes innovative products to serve the global cannabis market. The Company serves the Canadian adult-use markets under its HEXO Cannabis,...

Continue reading

HEXO Corp participera à la Wolfe Research Consumer Access Day le 26 mars 2021

OTTAWA, 23 mars 2021 (GLOBE NEWSWIRE) — HEXO Corp («  HEXO » ou la « Société ») (TSX : HEXO ; NYSE : HEXO) a annoncé aujourd’hui que Sébastien St-Louis, président-directeur général, et Trent MacDonald, chef de la direction financière, participeront à une séance de questions et réponses en direct dans le cadre du Wolfe Research Consumer Access Day, le 26 mars 2021. La discussion, prévue à 9h15 (HE), sera animée par Greg Badishkanian, directeur général et responsable du secteur de la consommation, et Spencer Hanus, analyste de recherche et responsable du secteur des produits de base. Pour plus d’informations, veuillez contacter votre représentant Wolfe Research. À propos d’HEXO (TSX : HEXO ; NYSE : HEXO) HEXO Corp est une entreprise primée de biens de consommation qui crée et distribue des produits innovateurs de cannabis...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.